Ischemic preconditioning impairs liver regeneration in extended reduced-size livers.
OBJECTIVE
To evaluate the effect of ischemic preconditioning (IPC) in an experimental setting of extended liver resection with 30 minutes of inflow occlusion in rats.


BACKGROUND
IPC has been proven an effective strategy against hepatic ischemia-reperfusion injury in both animal and human studies. However, decreased protective effects in terms of transaminase levels were found in patients with larger resection volume, questioning the benefit of IPC in case of small liver remnants.


METHODS
Rats undergoing 90% hepatectomy under strict inflow occlusion for 30 minutes were subjected to either receive or not receive an IPC period (5 minutes of ischemia followed by 30 minutes of reperfusion). In addition to 10-day survival rate, laser Doppler flowmetry of hepatic blood flow and fluorescence microscopic analysis of the hepatic microcirculation were performed to assess the effect of IPC on initial microvascular reperfusion of liver remnants after 90% resection. Moreover, regeneration capacity of livers undergoing IPC and 70% resection was studied over 7 days by means of histology and immunohistochemistry.


RESULTS
Ten-day survival of rats which underwent IPC and 90% hepatectomy was 0 out of 10 animals versus 1 out of 10 animals without IPC. Hemodynamic and microcirculatory analysis revealed signs of hyperperfusion during initial reperfusion of preconditioned liver remnants in 90% hepatectomized animals. In addition to increased transaminase levels, IPC impaired hepatic proliferative response after 70% organ resection, as indicated by both a significant reduction in mitotic figures and Ki-67 nuclear staining of hepatocytes, as well as a decrease in restitution of liver mass.


CONCLUSIONS
Though portal hypertension reflecting shear stress has been reported to trigger liver regeneration, remnant liver tissue after major hepatectomy may not benefit from hyperperfusion-induced trigger for cell cycle entry but is rather dominated from hyperperfusion-induced local organ injury. Further studies are required to finally judge on the harmfulness of IPC in extended liver resection.
Eipel
Christian
C
Department of Experimental Surgery, University of Rostock, Rostock, Germany.
Glanemann
Matthias
M
Nuessler
Andreas K
AK
Menger
Michael D
MD
Neuhaus
Peter
P
Vollmar
Brigitte
B
D000818:Animals; D002455:Cell Division; D006498:Hepatectomy; D007124:Immunoenzyme Techniques; D019194:Ischemic Preconditioning / Q000009:adverse effects*; D019394:Ki-67 Antigen / Q000032:analysis; D017078:Laser-Doppler Flowmetry; D008099:Liver / Q000737:chemistry / Q000473:pathology; D008102:Liver Circulation; D008115:Liver Regeneration; D008297:Male; D008833:Microcirculation; D008856:Microscopy, Fluorescence; D051381:Rats; D017208:Rats, Wistar
D019394:Ki-67 Antigen
Transplantation. 1999 Oct 27;68(8):1112-6
10551638
Ann Surg. 2003 Feb;237(2):256-64
12560784
J Gastrointest Surg. 2000 Jan-Feb;4(1):44-9
10631361
J Pathol. 2000 Feb;190(3):255-66
10685060
J Hepatol. 2000 Mar;32(3):508-15
10735623
Am J Physiol Heart Circ Physiol. 2000 May;278(5):H1565-70
10775134
World J Surg. 2003 Mar;27(3):356-64
12607066
Ann Surg. 2003 Mar;237(3):429-36
12616129
FASEB J. 2003 Apr;17(6):660-7
12665479
Liver Transpl. 2003 Jun;9(6):547-51
12783393
Am J Transplant. 2003 Aug;3(8):1003-9
12859537
J Gastroenterol Hepatol. 2003 Aug;18(8):891-902
12859717
Dig Surg. 2003;20(5):383-96
12840597
Liver Transpl. 2003 Sep;9(9):S29-35
12942476
Liver Transpl. 2003 Sep;9(9):S36-41
12942477
Gastroenterology. 2003 Sep;125(3):917-36
12949736
Transplant Proc. 1999 Dec;31(8):3260-2
10616469
Hepatology. 1999 Nov;30(5):1223-31
10534344
Gastroenterology. 2003 Nov;125(5):1480-91
14598265
J Hepatobiliary Pancreat Surg. 2003;10(3):189-94
14605974
Ann Surg. 2003 Dec;238(6):843-50; discussion 851-2
14631221
Surgery. 2004 Feb;135(2):203-14
14739856
Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G769-76
14715524
Biorheology. 1972 Dec;9(4):225-64
4579396
Microvasc Res. 1973 Sep;6(2):212-28
4748021
Circulation. 1986 Nov;74(5):1124-36
3769170
Br J Surg. 1992 Mar;79(3):224-6
1313324
J Am Coll Surg. 1994 May;178(5):454-8
8167881
Biochem Biophys Res Commun. 1996 Dec 4;229(1):264-70
8954116
Surgery. 1997 Feb;121(2):142-9
9037225
Annu Rev Pharmacol Toxicol. 1997;37:327-38
9131256
Hepatology. 1997 Sep;26(3):573-8
9303485
Am J Physiol. 1998 Jul;275(1 Pt 2):H243-9
9688920
Br J Surg. 1998 Dec;85(12):1636-40
9876065
Surg Today. 1999;29(1):1-9
9934824
Transplantation. 1999 Jan 27;67(2):321-7
10075602
Ann Surg. 1999 Mar;229(3):369-75
10077049
Can J Physiol Pharmacol. 1998 Dec;76(12):1072-9
10326828
J Hepatobiliary Pancreat Surg. 1999;6(3):275-80
10526063
Transplantation. 2000 Dec 27;70(12):1697-703
11152099
J Physiol. 2001 Feb 15;531(Pt 1):193-201
11179403
Arch Surg. 2001 Mar;136(3):280-5
11231846
Transplant Proc. 2001 Feb-Mar;33(1-2):956
11267143
Semin Liver Dis. 2001;21(1):105-13
11296690
Hepatogastroenterology. 2001 Mar-Apr;48(38):556-62
11379353
Am J Surg. 2001 Feb;181(2):160-6
11425059
J Hepatobiliary Pancreat Surg. 2001;8(5):461-8
11702257
Hepatology. 2002 Jul;36(1):94-102
12085353
J Hepatol. 2003 Jan;38(1):59-66
12480561
Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G15-26
12488232